Animalcare Group (ANCR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 217.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 223.00
  • 52 Week Low: 166.40
  • Currency: UK Pounds
  • Shares Issued: 60.11m
  • Volume: 2,200
  • Market Cap: £130.43m

Animalcare posts flat revenues as supply chain challenges dent sales

By Iain Gilbert

Date: Tuesday 23 Jul 2019

LONDON (ShareCast) - (Sharecast News) - Animal health business Animalcare posted flat revenues for the first half as sales were impacted by supply chain issues at a third-party manufacturer.
Revenues were steady at £36.1m, but the company did manage to record a 0.9% improvement on a constant currency basis.

Animalcare said this small improvement was "noteworthy", given previously reported supply challenges which impacted sales by £1.1m during the half.

"We are on track to resolve the supply issues during the current financial year which is anticipated to be reflected in sales during the second half," it said.

The company, which committed to reducing net debt and improving cash conversion, saw net debt come to £21m, down from the £23.6m on 31 December.

Chief executive Jenny Winter said: "We have a clear strategy to become a leading international veterinary pharmaceutical business and we have made good progress towards this goal during the first half of 2019.

"I am pleased that the growth platform that we have been focused on building is coming to fruition and I look forward to updating the market further on our progress."

At 1050 BST, Animalcare shares were up 3.85% to 162p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

ANCR Market Data

Currency UK Pounds
Share Price 217.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 223.00
52 Week Low 166.40
Volume 2,200
Shares Issued 60.11m
Market Cap £130.43m

ANCR Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
73.48% below the market average73.48% below the market average73.48% below the market average73.48% below the market average73.48% below the market average
28.30% above the sector average28.30% above the sector average28.30% above the sector average28.30% above the sector average28.30% above the sector average
Price Trend
44.15% above the market average44.15% above the market average44.15% above the market average44.15% above the market average44.15% above the market average
78.95% above the sector average78.95% above the sector average78.95% above the sector average78.95% above the sector average78.95% above the sector average
Income
72.93% below the market average72.93% below the market average72.93% below the market average72.93% below the market average72.93% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Growth
26.81% below the market average26.81% below the market average26.81% below the market average26.81% below the market average26.81% below the market average
13.51% below the sector average13.51% below the sector average13.51% below the sector average13.51% below the sector average13.51% below the sector average

What The Brokers Say

Strong Buy 0
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

ANCR Dividends

  Latest Previous
  Final Interim
Ex-Div 20-Jun-24 19-Oct-23
Paid 19-Jul-24 17-Nov-23
Amount 3.00p 2.00p

Trades for 25-Apr-2024

Time Volume / Share Price
08:03 2,200 @ 217.00p

ANCR Key Personnel

CFO Chris Brewster
CEO Jenny Winter

Top of Page